|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
Q3 FY2021
As of Jun 30, 2021
|
Q2 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Dec 31, 2020
|
Q4 FY2020
As of Sep 30, 2020
|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
Q1 FY2020
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Employee Advances | ||||||||||||||||||||
| Other Receivables | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Investment | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Other payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Deferred Compensation | ||||||||||||||||||||
| License Fees Payable | ||||||||||||||||||||
| Derivative liability warrants | ||||||||||||||||||||
| Payable to TN3 | ||||||||||||||||||||
| Accrued legal settlement | ||||||||||||||||||||
| Derivative and warrant liabilities | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Short term loan, related party | ||||||||||||||||||||
| Convertible promissory notes, net of debt discount and debt issuance costs of $122,302 and $0 respectively. Some are in default (see Note 5) | ||||||||||||||||||||
| Convertible promissory note related party, net of debt discount and debt issuance cost of $0 and $2,132, respectively | ||||||||||||||||||||
| Convertible promissory note related party | ||||||||||||||||||||
| Bridge Loans Payable - related parties | ||||||||||||||||||||
| Convertible loan payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Convertible promissory notes | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
| Preferred stock 50,000,000 shares authorized, shares issued and outstanding designated as follows: | ||||||||||||||||||||
| Preferred Stock Series B, $0.01 par value, 25,000 authorized and 600 shares issued and outstanding | ||||||||||||||||||||
| Total preferred Stock Series B, $0.01 par value, 25,000 authorized and 600 shares issued and outstanding | ||||||||||||||||||||
| Common stock, no par value; 2,000,000,000 authorized common shares 61,652,385 and 21,744,209 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Paid in capital, common stock warrants | ||||||||||||||||||||
| Paid in capital, preferred stock | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
Loading...
